Abstract

We present a new approach to the handling and interrogating of large flow cytometry data where cell status and function can be described, at the population level, by global descriptors such as distribution mean or co-efficient of variation experimental data. Here we link the “real” data to initialise a computer simulation of the cell cycle that mimics the evolution of individual cells within a larger population and simulates the associated changes in fluorescence intensity of functional reporters. The model is based on stochastic formulations of cell cycle progression and cell division and uses evolutionary algorithms, allied to further experimental data sets, to optimise the system variables. At the population level, the in-silico cells provide the same statistical distributions of fluorescence as their real counterparts; in addition the model maintains information at the single cell level. The cell model is demonstrated in the analysis of cell cycle perturbation in human osteosarcoma tumour cells, using the topoisomerase II inhibitor, ICRF-193. The simulation gives a continuous temporal description of the pharmacodynamics between discrete experimental analysis points with a 24 hour interval; providing quantitative assessment of inter-mitotic time variation, drug interaction time constants and sub-population fractions within normal and polyploid cell cycles. Repeated simulations indicate a model accuracy of ±5%. The development of a simulated cell model, initialized and calibrated by reference to experimental data, provides an analysis tool in which biological knowledge can be obtained directly via interrogation of the in-silico cell population. It is envisaged that this approach to the study of cell biology by simulating a virtual cell population pertinent to the data available can be applied to “generic” cell-based outputs including experimental data from imaging platforms.

Highlights

  • Multiparameter flow cytometry is widely used to study the cell cycle and its perturbation in the context of both basic research and in routine clinical analysis [1,2,3,4,5,6]. Such analyses may use a wide range of fluorescent reporters that correlate to the expression of key molecular components of the cell cycle, such as cyclins and cyclin dependent kinases (CDK), [1] or quantify DNA content [5]

  • Cell population simulation To illustrate the evolution of the vcell population, we generate a series of snap-shots derived at different temporal intervals (Figure 4 green population) demonstrating the simulated intensity dot plot at 6, 12, 18 and 24 hours respectively after initialisation by an experimental data set

  • The vcell population has a mean IMT of 22 hours and an associated standard deviation of 6 hours; a small subpopulation of vcells can be depicted a contour is displayed, indicating the extent of the gated experimental data set at initialisation

Read more

Summary

Introduction

Multiparameter flow cytometry is widely used to study the cell cycle and its perturbation in the context of both basic research and in routine clinical analysis [1,2,3,4,5,6]. Multi-variate approaches may involve discriminant function, cluster or principal component analysis in an n-dimensional space [10,11,12] In all of these approaches there is a common procedural thread: acquisition of data is followed by a statistical parameterisation of the measurement set to which biological form or function can be correlated. The cell-cycle information is read directly from the in-silico populations

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.